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The methylome is subject to genetic and environmental effects. Their impact may depend
on sex and age, resulting in sex- and age-related physiological variation and disease
susceptibility. Here we estimate the total heritability of DNA methylation levels in whole
blood and estimate the variance explained by common single nucleotide polymorphisms at
411,169 sites in 2,603 individuals from twin families, to establish a catalogue of between-
individual variation in DNA methylation. Heritability estimates vary across the genome
(mean¼ 19%) and interaction analyses reveal thousands of sites with sex-speciﬁc heritability
as well as sites where the environmental variance increases with age. Integration with
previously published data illustrates the impact of genome and environment across the
lifespan at methylation sites associated with metabolic traits, smoking and ageing.
These ﬁndings demonstrate that our catalogue holds valuable information on locations in
the genome where methylation variation between people may reﬂect disease-relevant
environmental exposures or genetic variation.
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O
f the many established epigenetic marks and mechanisms,
DNA methylation is thought to contribute to stable
long-term gene expression regulation and tissue
differentiation1, and is ideally suited for genome-wide
assessment in large human epidemiological studies2. A growing
body of literature illustrates that traits and diseases are associated
with DNA methylation variation3–7. DNA methylation
differences between individuals may result from differences in
environmental exposures8, stochastic variation and genetic
inﬂuences9. Increasing evidence suggests that genetically
induced epigenetic variation between individuals contributes to
human disease susceptibility5,10–12. Methylation differences have
been observed between the sexes13–15 and across age16–19,
suggesting that epigenetic regulation may also be involved in
the widely observed age and sex differences in life history traits
and the aetiology of complex diseases20,21.
It is well-known that genetically identical model organisms
such as cloned animals22, isogenic plants23 and inbred mice24
exhibit epigenetic and phenotypic differences. These organisms
and human identical twins offer insight into the impact of
environmental and stochastic inﬂuences on the epigenome. The
overall contribution of genetic and environmental differences,
from conception onwards, to variation in DNA methylation
between humans may be estimated by contrasting the correlation
between DNA methylation levels of monozygotic (MZ) and
dizygotic (DZ) twins, who share 100% and 50% of segregating
genetic variants that contribute to methylation differences,
respectively (the classical twin design). Based on previous twin
studies, the average heritability of methylation level on cytosine-
guanine dinucleotides (CpGs) across the genome has been
estimated between 5% and 19% for different tissues9,16,25,26, but
it is unknown what part can be explained by common genetic
variation and to what extent the impact of genetic and
environmental inﬂuences on DNA methylation depends on sex
and age. Studies of humans and rats have described sex-speciﬁc
effects of prenatal dietary exposures on DNA methylation27,28
and sex-speciﬁc epigenetic effects of in utero exposure to an
endocrine disruptor have been described in mice29. Some studies
indicated that certain epigenetic marks including DNA methyl-
ation diverge in twin pairs with ageing, suggesting ampliﬁcation
of environmental or stochastic effects on DNA methylation across
the lifespan30,31, although evidence for such effects is not always
observed26,32. A study of neonatal MZ twins reported that twin
pairs may show trajectories of divergent, convergent or
longitudinally stable methylation patterns after birth33. Examples
of sites where the relationships between age and DNA methylation
depends on genotype34 and sex-speciﬁc methylation quantitative
trait loci (QTL)35 have also been reported.
In the current study, we analyse data from a large cohort of
twins and family members in whom DNA methylation was
measured across the genome (Illumina 450k array) in whole
blood. We establish an accurate catalogue (presented in
Supplementary Data 1) of between-individual variation in DNA
methylation due to environmental effects, total genetic effects and
the effects of common genetic variants. We examine differences
in epigenetic regulation between the sexes and across age, and test
for interactions of genomic effects and environmental effects on
methylation with sex and age. Subsequently, we relate our
catalogue to previously published loci where DNA methylation is
sensitive to smoking, and loci that are epigenetically associated
with metabolic phenotypes, including serum metabolite levels,
lipid levels and body mass index (BMI). We demonstrate that
(1) many smoking-associated CpGs show epigenetic drift
(changes in methylation due to deregulated maintenance36)
with aging; (2) DNA methylation connected to complex traits is
characterized by genetically and environmentally induced
variation between individuals; and (3) the importance of the
environment increases with age at many sites.
Results
Heritable and environmental inﬂuences on DNA methylation.
We characterized the impact of genetic variation and environ-
mental inﬂuences on DNA methylation based on genome-wide
DNA methylation and SNP data from 2,603 individuals (mean
age¼ 37.2, s.d.¼ 13.3; 66% females; Table 1). The study sample
included twins (N¼ 2,373), parents of twins (N¼ 212), siblings of
twins (N¼ 16) and spouses of twins (N¼ 3). DNA methylation
data were available for 769 MZ and 424 DZ twin pairs.
Methylation levels at 411,169 autosomal sites were analysed.
Before analyses, DNA methylation levels were normalized and the
normalized methylation M values were adjusted for sex, age,
measured white blood cell percentages, the ﬁrst ten principal
components (PCs) from the genotype data, methylation array
row and sample plate (see Methods section). Of all analysed
methylation sites, methylation levels at 7% (N¼ 29,783) showed
a signiﬁcant (a¼ 1.2 10 7, gee model, z-test using robust
estimates) association with sex (Supplementary Fig. 1), and 33%
(N¼ 135,775) showed a signiﬁcant (cross-sectional) association
with age (Supplementary Fig. 2). White blood cell proportions
displayed the expected age-related trend, characterized by a
small positive correlation between neutrophil-to-lymphocyte
ratios and age (r¼ 0.10, P¼ 5.2 10 8, Pearson correlation;
Supplementary Fig. 3). Averaged over genome-wide methylation
sites, all predictors together explained on average 16%
of the variance in DNA methylation between individuals
(Supplementary Fig. 4). At most methylation sites, the s.d.
of DNA methylation level across individuals was small
(Supplementary Fig. 5).
Twin correlations (Table 2) suggested that additive genetic
inﬂuences mainly account for the resemblance of twins for DNA
methylation level; the average correlation in MZ twins (r¼ 0.20)
is approximately twice as large as the average correlation in DZ
twins (r¼ 0.09). The data from twins were used to ﬁt classical
ACE and ADE twin models that estimate the variance explained
by additive genetic effects (A), non-additive genetic effects (D),
common environment (C) and unique environmental effects (E)
at individual methylation sites (Supplementary Table 1). Note
that the variance term E includes stochastic variation and
measurement error. ACE models (Fig. 1a) showed that common
environmental effects shared by twins explained on average 3% of
the variance (s.d.¼ 5%) across all 411,169 methylation sites, with
signiﬁcant C effects (a¼ 1.2 10 7, likelihood ratio test) at 185
Table 1 | Characteristics of the subjects.
Sub-group/analysis N* Mean age (s.d.),
range
Sex
All subjects heritability
analyses
2,603 37.2 (13.3), 17–79 F: 1714, M: 889
MZ twin pairs 769 36.1 (12.4), 18–78 F: 541, M: 228,
DZ twin pairs 424 33.9 (10.5), 17–79 FF: 180, MM:
93, FM: 151
Subjects with longitudinal
methylation data
31 34.4 (6.1), 26–50w F: 24, M: 7
Subjects with blood and
buccal methylation data
22z 18y F: 16, M: 6
F, female; FF, female-female; FM, female-male; M, male; MM, male-male; MZ, monozygotic;
DZ, dizygotic.
*Number of subjects or twin pairs.
wAge at ﬁrst blood sample collection.
zSubjects were 11 MZ twin pairs.
yAll subjects were 18 years when blood and buccal samples were collected.
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methylation sites (0.04%). ADE models (Fig. 1b) showed that
non-additive genetics effects explained on average 8% of variance
in DNA methylation (s.d.¼ 12%), with signiﬁcant effects at 241
methylation sites (0.06%). Additive genetic inﬂuences had a larger
impact on the methylome, with signiﬁcant effects at 169,013
methylation sites (41%) and accounting for 20% of the variance
(s.d.¼ 21%) on average across all methylation sites in the
model including only A and E. In the same model, unique
environmental effects explained on average 80% of the variance
(s.d.¼ 21%).
Next, we estimated the additive genetic and unique environ-
mental variance by ﬁtting linear mixed models in which the
variance in DNA methylation was modelled as a function of
measured genetic relationships37 among 2,603 individuals. To
this end, we constructed a genetic relationship matrix (GRM)
based on all common genotyped autosomal SNPs (Affymetrix6
array, minor allele frequency (MAF)40.01). We applied the
method of Zaitlen et al.38, which allows for simultaneous
estimation of the total additive heritability of DNA methylation
level (hereafter referred to as h2) and h2SNPs (variance in DNA
methylation level explained by all variants in the genome tagged
by genotyped SNPs)37 in cohorts that include both closely and
distantly related individuals. Because of the limited evidence for
common environmental effects and non-additive genetic effects
genome-wide, all further analyses focused on additive genetic
effects and unique environmental effects.
We obtained estimates of h2 and h2SNPs at 407,373 sites (98.5%;
Fig. 2). The genome-wide average h2 was 0.19 (s.d.¼ 0.20), similar
to the estimate based on the classical twin method (mean
h2twins¼ 0.20), and the estimates of h2 and h2twins were strongly
correlated (r¼ 0.99). The results are similar to twin correlations
and h2twins based on Illumina 450k methylation data from
peripheral blood published previously based on smaller studies16,25.
Twin correlations and h2twins were on average larger at methylation
sites with a larger variance (Supplementary Table 2). Since
annotated SNPs underlying methylation probe binding sites at
positions other than the targeted CpG site did not have a substantial
effect on the heritability of DNA methylation (Supplementary
Fig. 6), we retained these methylation probes in the analyses.
Variance explained by common genetic variation in the genome.
Across all sites, on average 7% (s.d.¼ 12%) of the variance of
DNA methylation was explained by common genetic variants in
the genome (h2SNPs; Fig. 3a). On average the proportion of total
heritability explained by SNPs (h2SNPs/h2) was 0.37 (s.d.¼ 0.40)
(Table 2). At many sites, a relatively large proportion of total
estimated heritable variation in DNA methylation was explained
by common genetic variants (methylation sites with40.99 of the
total heritability explained by SNPs: N¼ 74,226, 18%). However,
at many sites DNA methylation is heritable, but common genetic
variants explain little of the genetic variance. The SNPs explained
o0.01 of the total heritability at 159,299 sites (39%). Moreover,
the proportion of variance explained by the unique environ-
mental component (E) was 0.81, highlighting the importance of
environmental and stochastic variation.
Differential heritability patterns across the genome.
Methylation sites with high heritability (h2Z0.5), low heritability
(h2o0.2), high SNP heritability (h2SNPsZ0.5) and low SNP
heritability (h2SNPso0.2) showed different distributions of
average methylation level (Fig. 3b) and magnitude of variance
across individuals (Supplementary Fig. 7). Sites with a high
heritability more often showed intermediate methylation levels
and their methylation levels were more variable. Sites with low
heritability were usually hypo- or hypermethylated, and their
methylation levels were less variable across individuals. We
compared sites with a high or low heritability with respect to ﬁve
gene-centric annotations by mapping them to proximal promoter
and distal promoter region, gene body, downstream region and
intergenic regions (Supplementary Data 2). We also compared
high and low heritable methylation sites with respect to the
CpG density of the underlying DNA sequence by mapping CpG
islands (CGI), CGI shores, shelves and non-CGI regions
(Supplementary Data 2). Across all assessed sites, highly heritable
sites showed signiﬁcant (a¼ 4.27 10 4, w2-test) enrichment in
CGI shores (Po2.2 10 16, w2-test), intergenic regions
(Po2.2 10 16, w2-test), distal promoter (Po2.2 10 6,
w2-test) and downstream region (Po2.2 10 16, w2-test), which
show more variation between people in general, and were
depleted in proximal promoter (Po2.2 10 16, w2-test), CGIs
(Po2.2 10 16, w2-test), and shelves (Po2.2 10 16, w2-test),
which generally display the smallest variation (Supplementary
Figs 8 and 9). Importantly, sites with very small variation tend to
be biologically invariable, implying that most observed variation
may represent technical noise.
To compare highly heritable sites and sites where most
variation is stochastic or environmental, we focused on 101,875
methylation sites (25% of all) showing most variation between
individuals (standard deviation of the methylation proportion
40.03; hereafter called variable methylated sites), which included
33,329 sites with high heritability, 18,860 sites with low
heritability, 5,623 sites with high SNP heritability and 71,788
with low SNP heritability. Exemplary scatterplots of DNA
methylation levels in MZ and DZ pairs at sites from each of
these categories are provided in Fig. 1c and in Supplementary
Figs 10–13. Among variable methylated sites, sites with high
heritability and sites with low heritability displayed comparable
distributions of total methylation variance (Supplementary
Fig. 14). Yet, they showed distinct distributions across genomic
regions: Taking all variable methylated sites as reference
(Fig. 3c,d), variable methylated sites with low heritability were
over-represented in gene bodies (Po2.2 10 16, w2-test), distal
promoter (P¼ 1.5 10 9, w2-test), CGI shelves (Po2.2 10 16,
w2-test) and non-CGI regions (Po2.2 10 16, w2-test), and
were underrepresented in proximal promoter (Po2.2 10 16,
w2-test), intergenic (Po2.2 10 16, w2-test), downstream
(P¼ 1.8 10 4, w2-test), CGIs (Po2.2 10 16, w2-test) and
shores (Po2.2 10 16, w2-test). Variable methylated sites
with a low heritability were more often hypermethylated
(Supplementary Fig. 15). By contrast, variable methylated sites
Table 2 | Twin correlations, heritability and variance
explained by common genetic variants for DNA methylation
level at all autosomal CpGs.
Parameter Min Median Mean Max
rMZ 0.14 0.12 0.20 0.99
rDZ 0.25 0.06 0.09 0.89
h2 0.00 0.12 0.19 0.99
hSNPs
2 0.00 0.01 0.07 0.98
hSNPs
2 /htotal
2 0.00 0.22 0.37 1.00
h2 Men* 0.00 0.13 0.20 1.00
h2 Women* 0.00 0.13 0.20 1.00
h2 Age 25w 0.00 0.14 0.21 0.99
h2 Age 50w 0.00 0.11 0.18 0.99
rMZ, correlation between DNA methylation levels of monozygotic (MZ) twins; rDZ, correlation
between DNA methylation levels of dizygotic (DZ) twins; h2, heritability of DNA methylation
level; hSNPs
2 , Proportion of variance of DNA methylation explained by genome-wide common
SNPs (MAF 40.01).
*Heritability of DNA methylation level in men and women, respectively, as estimated by sex
interaction models on all genome-wide autosomal methylation sites.
wHeritability of DNA methylation level at age 25 and age 50, respectively, as estimated by age
interaction models on all genome-wide autosomal methylation sites.
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with a high heritability showed an opposite pattern of enrichment
compared with low heritability sites (Fig. 3c,d; Supplementary
Data 2), and included many sites with intermediate methylation
levels (Supplementary Fig. 15). We also overlaid the most highly
heritable and the least heritable variable methylated sites with
locations of DNase I hypersensitive sites (DHSs) in 299 individual
cellular samples from the Epigenomics Roadmap project39.
Highly heritable methylation sites showed strong enrichment in
DHSs across a number of cell types (Supplementary Data 3),
while the least heritable methylation sites were depleted in DHSs
of the majority of tissues (Supplementary Data 4). The large
majority of probes on the Illumina 450k array target CpG sites,
but a small percentage (0.6% of all probes on the array) measure
non-CpG methylation. We observed enrichment of non-CpG
probes among sites with low heritability (1.7% non-CpG,
Po2.2 10 16, w2-test, Supplementary Data 5), and depletion
among sites with high heritability (0% non-CpG,
Po2.2 10 16, w2-test).
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Figure 1 | Genetic and environmental inﬂuences on genome-wide DNA methylation levels. Estimates from classical twin modelling in 769 MZ and 424
DZ twin pairs. (a) Histograms of genome-wide ACE model estimates: variance explained by additive genetic effects (a2, red), common environmental
effects (c2, purple) and unique environmental effects (e2, green). (b) Histograms of genome-wide ADE model estimates: variance explained by additive
genetic effects (a2, red), non-additive genetic effects (d2, dark purple) and unique environmental effects (e2, green). Y axes are truncated. (c) Scatterplots
of DNA methylation levels in MZ and DZ twin pairs at four exemplary CpG sites. The DNA methylation level in twin 2 (y axis) is plotted against the DNA
methylation level in twin 1 (x axis) for all MZ twin pairs and all DZ twin pairs. For illustrative purposes, methylation b-values (which represent methylation
proportion) obtained after normalization are plotted in this ﬁgure, whereas all analyses were performed on normalized methylation M values, corrected for
a number of covariates (see Methods section). Four examples of CpG sites were selected from the most variable CpG sites (s.d.40.03) with high
heritability (h2¼0.56; upper left), high SNP heritability (h2SNPs¼0.81; upper right), low heritability (h2¼0.18; lower left) and low SNP heritability
(h2SNPs¼0.00, lower right). Note that the larger the difference between the correlation in MZ twins and in DZ twins (stronger correlation in MZ twins), the
higher the total heritability. The resemblance of MZ and DZ twins is not informative with respect to the amount of variance explained by genome-wide
SNPs. Additional examples are plotted in Supplementary Figs 10–13.
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To further characterize sites with high versus low heritability,
we analysed longitudinal peripheral blood DNA methylation data
from 31 individuals (mean age 34 years; Table 1) collected with
an interval of on average 5 years, and DNA methylation data
from blood and buccal samples that were available for 22
individuals (age 18 years; Table 1). At highly heritable sites, the
methylation level in blood on average was stable over time (mean
r¼ 0.73, median¼ 0.76), as previously observed40 and correlated
weakly on average with methylation level in buccal cells (mean
r¼ 0.28, median¼ 0.28), whereas sites with a low heritability
were not stable (longitudinal correlation: mean r¼ 0.08, median
r¼ 0.08) and did not correlate with methylation level in buccal
cells (correlation with buccal: mean r¼ 0.00, median r¼ 0.00).
Thus, genetic inﬂuences may underlie stability and cross-tissue
correlations for DNA methylation level41
Notably, we also observed variable methylated sites with low
heritability and high stability across time. Sites that varied mostly
due to environmental or stochastic inﬂuences and that were
longitudinally stable (longitudinal rZ0.5, N¼ 542) were
signiﬁcantly underrepresented in CpG islands (Po1.0 10 7,
w2-test). Longitudinally unstable sites with a large environmental
component (longitudinal ro0.2, N¼ 13,660) were signiﬁcantly
over-represented in shelves (Po2.2 10 16, w2-test), non-CGI
sites (Po2.2 10 16, w2-test), gene bodies (Po2.2 10 16,
w2-test), and distal promoters (Po4.2 10 7, w2-test) and
were depleted in CGIs (Po2.2 10 16, w2-test), shores
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Figure 2 | Heritability of DNA methylation level across the genome.
Estimates of DNA methylation heritability from the GRM-based approach in
2,603 individuals. From inside to outside: the most inner circular diagram
displays the average methylation level at each site, the second band shows
the total heritability of DNA methylation level, the third band shows the
SNP heritability of DNA methylation level, and the most outer circle shows
the chromosome ideograms. Colours range from dark blue (0%) to dark red
(100%).
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Figure 3 | Variance explained by SNPs and longitudinal stability. (a) Histogram of total additive heritability (h2 total) of DNA methylation (green) and
variance explained by genome-wide SNPs (h2 SNPs, purple) for genome-wide CpGs. The y axis is truncated. (b) Density plot of methylation sites with a
high versus low heritability. (c) Distribution of methylation sites grouped based on heritability and longitudinal stability relative to genes: DP, distal
promoter; DS, downstream region; GB, gene body; IG, intergenic; PP, proximal promoter. (d) Distribution of methylation sites grouped based on heritability
and longitudinal stability in relation to CpG density: CGI, CpG island; NC, non-CGI; SHE, CpG island shelf; SHO, CpG island shore. Asterisks denote
signiﬁcant enrichment or depletion (a¼4.27 104, w2-test). Results of DNA methylation heritability are from the GRM-based approach in 2,603
individuals. Longitudinal stability was assessed in 31 subjects with data from two longitudinally collected blood samples.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11115 ARTICLE
NATURE COMMUNICATIONS | 7:11115 | DOI: 10.1038/ncomms11115 | www.nature.com/naturecommunications 5
(Po2.2 10 16, w2-test), intergenic (Po2.2 10 16, w2-test),
proximal promoter (Po2.2 10 16, w2-test) and downstream
region (Po2.3 10 5, w2-test).
Genetic and environmental effects vary by sex and age.
We examined interaction effects between sex and total genetic
effects and between sex and unique environmental effects on
methylation levels (see Methods section). Sex interaction models
were ﬁtted successfully for 391,227 sites (95%). The genome-wide
average heritability was nearly identical in males (mean
h2¼ 0.199, median¼ 0.13) and females (mean h2¼ 0.198,
median¼ 0.13). Signiﬁcant interaction (a¼ 1.3 10 7, w2-test)
between sex and genetic or environmental effects was evident at
2,667 sites (0.7%; Fig. 4a). At 59% of these sites (that is, 1,572)
heritability was lower in women (Supplementary Fig. 16).
In a similar manner, we ﬁtted models that included age as a
continuous interaction term. Age interaction models were ﬁtted
successfully for 379,638 sites (92%). We found signiﬁcant
interaction (a¼ 1.3 10 7, w2-test) between age and genetic or
environmental effects on DNA methylation at 39,455 sites
(10.4%; Fig. 4b). Sex- and age-related differences in heritability
may be caused by a difference in the environmental variance or
by a difference in the genetic variance. Although both may also
occur simultaneously, this is not a general rule. In fact, we found
that at 32,234 sites (82%) with signiﬁcant age interaction, and at
2,034 sites (76%) with signiﬁcant sex interaction, it was the
environmental variance (rather than the additive genetic
variance) that was subject to a signiﬁcant effect of age or sex. This
observation highlights that across the genome, environmental
or stochastic inﬂuences are a more important determinant of
sex-speciﬁc and age-speciﬁc methylation variation between
individuals than genetic inﬂuences.
At sites with signiﬁcant age interaction, the total variance in
DNA methylation between individuals generally increases with
age, whereas the proportion of variance explained by genetic
inﬂuences (heritability) decreases, at least up to age 60 (Fig. 5a).
While the environmental variance increases at most of these sites
across the age range studied, the additive genetic variance initially
decreases at most sites, but increases at later ages. At 90% of sites
with signiﬁcant age interaction, the heritability was lower at age
50 than at age 25 (Fig. 5b). At most sites, the change in
heritability was modest (Supplementary Fig. 17), but large
differences also occurred. For example, there were 104 sites
where the change in heritability was larger than 0.5 between age
25 and age 50. Only 21 of these sites were longitudinally stable
across 5 years.
Genomic distribution of sex and age interaction effects. While
a small proportion of sites shows multiple types of interaction
(that is, age and/or sex by genetic and/or environmental inﬂu-
ences, Fig. 6a), interactions involving genetic and those involving
environmental inﬂuences were not equally distributed across
genomic sites (Supplementary Data 2). Interactions between
environmental effects and age occurred mainly at sites with an
intermediate average methylation level (Fig. 6b), and were
signiﬁcantly over-represented (a¼ 4.27 10 4, w2-test) in inter-
genic regions, distal promoters, downstream regions (P values
o2.2 10 16, Fig. 6c) and CGI shores (Po2.2 10 16, w2-test;
Fig. 6d) and underrepresented in gene body, proximal promoter,
CGI, non-CGI and shelf (P valueso2.2 10 16, w2-test). On the
other hand, interactions between genetic effects and age occurred
more often at hypomethylated sites (Fig. 6b) and were enriched in
proximal promoters (Po2.2 10 16, w2-test; Fig. 6c) and CGIs
(Po2.2 10 16, w2-test; Fig. 6d) and depleted in gene body
(Po2.2 10 16, w2-test), intergenic (P¼ 2.2 10 9, w2-test),
non-CGI regions (Po2.2 10 16, w2-test), shores (P¼ 7.2
 10 5, w2-test) and shelves (P¼ 1.3 10 7, chi-square test).
Sites with sex by environment interaction were usually hypo-
or intermediately methylated (Fig. 6b) and were enriched
in proximal promoters (Po2.2 10 16, w2-test) and CGIs
(Po2.2 10 16, w2-test), and underrepresented in gene bodies
(P¼ 3.6 10 13, w2-test), non-CGI (P¼ 3.0 10 13, w2-test)
and shelves (P¼ 2.2 10 6). Sites with signiﬁcant interaction
between sex and total genetic effects were more often hyper-
methylated (Fig. 6b), were over-represented in gene bodies
(P¼ 1.3 10 4, w2-test) and underrepresented in proximal
promoters (Fig. 6c, P¼ 1.4 10–5, w2-test), and showed no
signiﬁcant differences in distribution relative to CpG density
(Fig. 6d). Sites with signiﬁcant age by genome or sex by genome
interaction were not enriched or depleted in DHSs of any cell type
from Epigenomics Roadmap data (Supplementary Data 6 and 7).
By contrast, sites with signiﬁcant interaction between environ-
mental effects and age showed signiﬁcant overlap with DHSs
of several types of fetal cells, embryonic stem cells and IPS
cells (Supplementary Data 8). Sites with interaction between
environmental effects and sex showed enrichment for DHSs
across all tissue types (Supplementary Data 9). Interaction
between environmental effects and sex on methylation was also
enriched among non-CpG sites, while interactions of both
genomic and environmental effects with age were depleted
among these sites (P valueso 2.2 10 16, chi-square test,
Supplementary Data 5).
Some smoking-associated CpGs show epigenetic drift with age.
To further examine the biological relevance, and to gain insight
into the causes that may underlie genetically and environmentally
induced methylation variance, we compared our ﬁndings
with genome-wide signiﬁcant methylation hits from previously
published epigenome-wide association studies (EWASs), that is;
CpGs where the methylation level in blood is associated with a
complex trait or exposure. We ﬁrst focused on smoking, which
has well-replicating associations with DNA methylation level at
many CpGs. We examined 430 CpGs associated with current
smoking based on the most recently published EWAS8.
One smoking-associated CpG showed a sex difference in
the environmental variance and two smoking-associated
CpGs showed a difference in the additive genetic variance
(Supplementary Data 10). Comparing smoking-associated
locations with 39,455 sites with signiﬁcant age interaction,
overlapping sites included one site that showed age by genome
interaction and 65 sites that displayed interaction between
environmental effects and age (Supplementary Data 10).
Methylation level at cg12803068 in MYO1G, associated with
smoking and among our top hits for the interaction between age
and environment (Po1 10 16, w2-test), had a heritability of
0.91 at age 25 and a heritability of 0.71 at age 50. To verify the
contribution of smoking to the changing environmental variance
with age at all 65 sites, we examined their methylation level in
monozygotic twins concordant and discordant for smoking
(Fig. 7). Methylation levels were more strongly correlated in
smoking-concordant monozygotic twins (concordant current
smokers, mean r¼ 0.64, concordant never smokers, mean
r¼ 0.63) than in smoking-discordant twins (discordant for
smoking ever, mean r¼ 0.44). This observation conﬁrms the
role of smoking in the increasing environmental variance with
increasing age at these sites. Smoking-associated sites were on
average moderately heritable (h2 mean¼ 0.50, s.d.¼ 0.15),
illustrating the presence of both genetic and environmental
effects on methylation. It is important to note that smoking itself
is a heritable trait.
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Trends in variance at CpGs associated with metabolic traits.
We next studied sites where DNA methylation level in blood is
associated with metabolic traits, including two CpGs identiﬁed
by an EWAS meta-analysis of BMI3 (h2¼ 0.72, and h2¼ 0.88,
respectively), eight CpGs associated with lipid levels6
(triglycerides, high-density lipoprotein (HDL) or low-density
lipoprotein (LDL), h2 mean¼ 0.45, s.d.¼ 0.12), and 1185 CpGs
associated with the levels of a number of distinct serum
metabolites42 (h2 mean¼ 0.29, s.d.¼ 0.17). Of metabolite-
associated sites, 51 showed age by genome interaction,
70 showed age by environment interaction, one showed sex by
genome interaction, and 7 showed sex by environment
interaction (Supplementary Data 11). One of the 8 published
CpGs associated with lipids showed an interaction effect in our
data: at higher ages, unique environmental inﬂuences accounted
for increasing variation in DNA methylation level at cg22178392
in the TNIP1 gene, of which DNA methylation level in blood and
adipose tissue is associated with serum LDL cholesterol level6.
The heritability of DNA methylation at this site in blood
decreases from 0.54 at age 25 to 0.39 at age 50. Metabolite-
associated CpGs displaying a sex difference in the environmental
variance include two associated with tryptophan levels, two
associated with mannose, and one associated with 5-oxoproline
levels (Supplementary Data 11). These point to differences
between men and women in the prevalence or impact of
exposure to relevant environmental factors that act upon
epigenetic regulation of metabolite loci.
Trends in variance across age at the epigenetic clock. Finally, we
examined 353 CpGs included in the epigenetic clock algorithm
that predicts DNA methylation age (DNAmAge) across a whole
range of tissues18. ‘DNA methylation age acceleration’ of blood,
deﬁned as the difference between DNAmAge and chronological
age, was previously found to predict mortality43 and to be
associated with a number of physical and cognitive ﬁtness
measures44. Of the clock CpGs, 55 showed interaction between
age and genetic or environmental effects (Supplementary
Data 12); at 49 clock sites the heritability of DNA methylation
level was lower at age 50 compared with age 25, illustrating that
environmental and/or stochastic inﬂuences account for an
increasing portion of the variance between people at higher
ages at these sites. This observation is consistent with the ﬁnding
that the heritability of ‘DNA methylation age acceleration’
predicted by these sites is lower in older populations18. It also
illustrates that there are sites in the genome where the
methylation level changes with age, and where there is an age-
related shift in the causes of variation between people. This shift
generally involves an increase in the impact of environmental or
stochastic inﬂuences with increasing age. Importantly, our data
suggest that this phenomenon not only affects sites where the
mean methylation level changes with age (such as the ‘clock
CpGs’) but also occurs at sites where the average methylation
level remains stable across ages (Fig. 4b).
In conclusion, these ﬁndings illustrate that our catalogue
(Supplementary Data 1) holds valuable information on locations
in the genome where methylation variation between people may
reﬂect disease-relevant environmental exposures or genetic
variation. Our ﬁndings also illustrate that DNA methylation
variation at single sites generally shows evidence of both genetic
and environmental inﬂuences.
Discussion
We assessed DNA methylation levels in peripheral blood in a
large population-based twin cohort, also including family
members of twins, and provide a catalogue characterizing the
methylation variance of loci along the genome according to
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genetic and environmental inﬂuences and the interaction of these
inﬂuences with age and sex (Supplementary Data 1). The
genome-wide average heritability (h2) of methylation level was
0.19. Our measured common genetic variants explained on
average 7% (h2SNPs) of the methylation variance. Common
genetic variants explained on average 37% of the total heritability
of methylation level (that is, 0.07/0.19). At 18% of the 450k
targeted sites, over 99% of the heritability was explained by
common SNPs. Yet, our ﬁndings also emphasize that an
important part of the heritability of DNA methylation in the
genome is not explained by common genetic variants, high-
lighting the importance of rare variants and structural variants
that are not or incompletely tagged by common SNPs on the
genotype array.
These ﬁndings highlight the importance of environmental and
stochastic inﬂuences on DNA methylation. Interaction analyses
indicated that age and sex-speciﬁc heritability of DNA methyla-
tion at speciﬁc sites is mainly driven by age and sex-speciﬁc
trends in the environmental variance. In support of previous
indications that certain epigenetic marks may diverge between
monozygotic twins with age30,31 (a phenomenon referred
to as epigenetic drift), our study revealed a large number of
methylation sites where the impact of environmental or stochastic
inﬂuences on DNA methylation increased with age. Such sites
may thus be used to monitor personalized effects of extrinsic and
intrinsic factors inﬂuencing physiology. We hypothesize that
interactions of genetic and environmental effects on DNA
methylation with age may be driven by individual differences in
intrinsic processes that change with ageing and by accumulating
effects of the response to exposures to environmental inﬂuences
during the lifespan.
Although methylation sites with high and low heritability were
observed throughout the genome, comparison of their genomic
distribution, taking the most variable sites between people as the
reference, revealed that highly heritable sites were enriched,
amongst others, in CpG islands and DHSs, while sites where most
variation was due to environmental or stochastic inﬂuences were
depleted in DHSs, CpG islands and proximal promoters and were
over-represented in CGI shores, shelves, gene body and distal
promoters, especially when longitudinally unstable across B5
years. Methylation sites showing signiﬁcant interaction between
environmental effects and age were most strongly enriched in
CGI shores. CpG islands and proximal promoters generally show
little variation in DNA methylation between people. It is thought
that methylation at promoter CpG islands serves a role in long-
term repression of genes such as developmental genes and
imprinted genes45,46. By contrast, previous studies have shown
that DNA methylation in CGI shores is the most dynamic across
tissues and throughout development47–49. Our ﬁndings suggest
that variation in DNA methylation at proximal promoter CGIs as
well as DHSs is generally relatively low, leaving genetic
differences as the main source for remaining variation between
people, while methylation in shores, shelves, non-CGI sites and
gene bodies may be more dynamic and more susceptible to
environmental or stochastic inﬂuences.
This study has several strengths and limitations. Our study is
the most comprehensive study to date examining the importance
of genetic and environmental inﬂuences to individual variation in
the human methylome. Yet, this study is limited to DNA
methylation measured at a limited number of genome-wide sites
in an accessible peripheral tissue. It remains to be examined how
representative our ﬁndings are for the situation in other tissues,
for DNA methylation genome-wide, and for epigenetic marks
other than DNA methylation. Although our study included
subjects in a very broad age range (17–79 years), it did not cover
the entire human lifespan and our interaction analyses were
limited to cross-sectional data. Because many human diseases are
thought to originate early in life, further studies examining the
pre- and postnatal causes of variation in DNA methylation
during early development would be extremely valuable.
Furthermore, more extensive longitudinal methylation datasets
allow better assessment of the genetic and environmental
inﬂuences on longitudinal stability of methylation levels. By
examining sex and age, we considered only a minor subset of
medically relevant covariates that may potentially moderate the
impact of genetic and environmental inﬂuences on DNA
methylation. A previous study reported several in utero environ-
mental factors that inﬂuenced neonate DNA methylation levels in
a genotype-speciﬁc way, highlighting the importance of genotype
by environment interaction50. Extension of the interaction model
that we used in this study51 would allow for the quantiﬁcation of
polygenic gene by environment interaction with measured
environmental proxies.
We demonstrated the trends in genetic and environmental
variance displayed by sites where DNA methylation level is
associated with metabolic traits and smoking, highlighting sites
where the environmental or genetic variance of DNA methylation
shows differences between males and females or across the
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life span. Environmental inﬂuences on the epigenome may
encompass many more types of exposures, including nutrition52,
exposure to chemicals/pollutants29,53, stress54 and others55.
In conclusion, we have provided a catalogue (Supplementary
Data 1) of genetic and environmental inﬂuences on DNA
methylation along the genome that can be used to obtain
insight into the causes of (sex- and age-speciﬁc) variation in DNA
methylation at (putative) disease loci.
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Methods
Subjects and samples. The subjects in this study participated in the Netherlands
Twin Register (NTR) biobank project56. Venous blood samples were drawn in the
morning after an overnight fast, and multiple EDTA and other tubes were collected
for isolation of DNA and assessment of haematological proﬁles. Blood, urine and
buccal sample collection procedures were described in detail previously56.
The study also included parents of twins, siblings of twins and spouses of twins.
In total, 3,264 blood samples from 3,221 NTR participants were assessed for
genome-wide methylation, of which 3,089 samples from 3,057 subjects passed
quality control. Only samples with good-quality DNA methylation data and with
white blood cell counts were retained for analysis, leaving 3,006 samples from
2,975 subjects. This dataset included 769 MZ and 424 DZ pairs. In 31 subjects
longitudinal methylation data were available (two time points, mean range¼ 5.2
years, s.d.¼ 1.1, range¼ 2–7 years). All analyses that included genome-wide SNP
data were performed on data from a subset of subjects who were genotyped and
who were of Dutch origin (N¼ 2,603).
For a small subset of 11 MZ pairs (male pairs¼ 3, female pairs¼ 8, age:
18 years), genome-wide methylation data were available for two types of samples:
blood (as described above) and buccal. The buccal samples from 10 twins were
assessed in 2013, as described by van Dongen et al.57. The 12 additional buccal
samples were assessed using the same protocol in 2014. Buccal and blood samples
were collected around the same date.
All subjects provided written informed consent. The study protocols were
approved by the Central Ethics Committee on Research Involving Human Subjects
of the VU University Medical Centre, Amsterdam, an Institutional Review Board
certiﬁed by the US Ofﬁce of Human Research Protections (IRB number IRB-2991
under Federal-wide Assurance-3703; IRB/institute codes, NTR 03-180).
Cell counts. The following subtypes of white blood cells were counted in blood
samples: neutrophils, lymphocytes, monocytes, eosinophils and basophils56.
Lymphocyte and neutrophil percentages were strongly negatively correlated
(r¼  0.93). Of these two white blood cell subtypes, the percentage of neutrophils
showed the strongest correlation with DNA methylation levels (as evidenced by the
correlation with PCs from the raw genome-wide methylation data). Basophil
percentage showed little variation between subjects, with a large number of subjects
having 0% of basophils. Therefore, the percentages of neutrophils, monocytes and
eosinophils were used to adjust DNA methylation data for inter-individual
variation in white blood cell proportions.
Genome-wide SNP data. Three distinct genotype data sets were available. The
ﬁrst consisted of previously collected genome-wide SNP data that were only used as
part of the quality control (QC) procedure of the DNA methylation data. The
second previously collected genome-wide SNP data were used only as part of the
statistical analyses of the DNA methylation data. The third SNP dataset consisted
of 65 common SNPs targeted by the Illumina 450k array that were only used as
part of QC procedure of the DNA methylation data.
Genotype data used during QC of the DNA methylation data. Of the 3,221
subjects for whom peripheral blood methylation samples were assessed with the
Illumina 450k array, 2,665 subjects had been previously genotyped or had a MZ
co-twin who had been genotyped one or multiple times on any of the following
genotype arrays: Affymetrix6, Affymetrix-Perlegen and Illumina660. One set of
genotypes was selected (the one with the best quality) for MZ twins if both twins
were genotyped and for individuals who had been genotyped on multiple
platforms. In total, 1,870 genome-wide SNP data sets were available, which were
informative for 2,665 individuals (including 795 MZ co-twins). For the DNA
methylation data QC, the overlapping SNPs from the Affymetrix6, Affymetrix-
Perlegen and Illumina660 arrays were selected. Because of the small overlap of
SNPs on these three arrays, this data set was not used for the heritability analyses of
DNA methylation.
Genotype data used in the heritability analyses. The analyses of DNA
methylation heritability were performed using genome-wide SNP data collected
with the Affymetrix6 array and SNP data that were extracted from whole-genome
sequence data that were available for a small subset of subjects (described
previously)58. Of the 2,975 subjects with good-quality DNA methylation data and
data on white blood cell counts, Affy6 genotype data were available for 2,289
subjects and sequence data for 341 individuals (numbers include both MZ twins).
Only SNPs present on the Affy6 platform were extracted from the sequence data.
For a subset of 84 subjects for whom sequence data and Affy6 data were available,
the sequence data was selected. SNPs with an allele frequency difference between
individuals genotyped on Affy6 and individuals who were sequenced were removed
(N¼ 2,645 SNPs, based on a P valueo1 10 5 in a case-control genome-wide
association analysis, where case-control status reﬂected whether a person was
genotyped on Affy6 or whole-genome sequenced). The genome-wide SNP data
were used to construct a GRM, which summarizes overall genetic relatedness
between all subjects (N¼ 2603) based on all genotyped autosomal SNPs
(MAF40.01) with genome-wide complex trait analysis (GCTA)59.
Inﬁnium HumanMethylation450 BeadChip data. DNA methylation was
assessed with the Inﬁnium HumanMethylation450 BeadChip Kit (Illumina)60.
Genomic DNA (500 ng) from whole blood was bisulﬁte treated using the
ZymoResearch EZ DNA Methylation kit (Zymo Research Corp, Irvine, CA, USA),
following the standard protocol for Illumina 450k micro-arrays, by the department
of Molecular Epidemiology from the Leiden University Medical Center (LUMC),
The Netherlands. Subsequent steps (that is, sample hybridization, staining,
scanning) were performed by the Erasmus Medical Center micro-array facility,
Rotterdam, The Netherlands.
DNA methylation quality control and probe ﬁltering. Quality control and
processing of the DNA methylation data from buccal samples has been previously
described57. The following text describes the quality control and processing of the
DNA methylation data from blood samples. The raw intensity ﬁles (idat) were
imported into the R environment61, where further processing, quality control and
normalization took place using a protocol developed by the LUMC Molecular
Epidemiology department.
First, the methylation data were examined with the R-package MethylAid62,
which marks outlier samples for a number of quality metrics that are computed
based on sample dependent and sample independent quality metrics. The
performance of the 3,264 samples is plotted for each of ﬁve quality metrics in
Supplementary Figs 18–22. Only samples that passed all ﬁve quality criteria (using
the default MethylAid thresholds) were kept for further analyses. In total, 70 low-
performing samples were excluded (2.1%), the majority of which failed based on
multiple criteria (Supplementary Table 3). Only the 3,194 samples showing good
overall quality were taken on to further processing steps.
Several probe-level QC steps were performed to ﬁlter out probes with low
performance. For all samples, ambiguously mapped probes were excluded, based
on the deﬁnition of an overlap of at least 47 bases per probe from Chen et al.63,
and all probes containing a SNP, identiﬁed in the Dutch population58, within the
CpG site (at the C or G position) were excluded, irrespective of minor allele
frequency. For each sample individually, probes with an intensity value of zero
(not present on the array of a particular sample), probes with a detection P
value40.01 (calculated using the function detectionP from the minﬁ package64),
and probes with a bead count o3 were excluded. After these steps, probes with a
success rateo0.95 across samples were removed from all samples and the success
rate across probes for each sample was computed (Mean per sample success
rate¼ 99.89%, range¼ 97.86–99.96%). The total number of CpGs after these
ﬁltering steps was 421,119. Only autosomal sites were kept in the current analyses
(N¼ 411,169).
We performed several checks to conﬁrm sample identity, by making use of
previously collected genotype data, 65 SNP (control) probes targeted by the
Illumina 450k array, and differential methylation patterns in men versus women.
Previously collected raw genotype data was used as input for the programme
MixupMapper, which computes the probability that a DNA methylation sample
matches supplied genotype information based on mQTLs estimated from the
dataset65. To conﬁrm sex, we clustered samples based on their methylation data, by
calculating the Euclidean distance from the pair-wise correlations between samples
followed by hierarchical clustering (cluster method¼ complete linkage). Clustering
based on all probes and clustering based on probes in the sex chromosomes yielded
similar results. We computed the correlation between samples for 65 SNP (control)
probes targeted by the 450 k array to conﬁrm zygosity of twins, and to conﬁrm that
longitudinal samples indeed belonged to the same person. Finally, we used the 65
SNP probes to examine potential contamination of samples with foreign DNA, by
computing the number of SNPs per sample with an unclear genotype (which we
deﬁned as SNPs where the proportion of signal from each allele lay between 0.2
and 0.4 or between 0.6 and 0.8, on a scale from 0 to 1, that is, a pattern not clearly
supporting membership to any of the three genotype classes). The number of
‘unclear genotypes’ showed a mean of 3.3 across all samples (median¼ 2, s.d.¼ 3.5,
Supplementary Fig. 23). We excluded samples with Z15 unclear genotypes
(99th percentile). The genome-wide methylation distribution of these excluded
samples showed relatively more intermediate methylation levels (Supplementary
Fig. 24). An example scatterplot of the 65 SNP probes in MZ twin samples
illustrating DNA contamination of the sample of one of the twins, as detected by
this method, is given in Supplementary Fig. 25.
In total, 132 samples were involved in at least one of the following issues:
genotype mismatch, sex mismatch, DNA contamination, and inconsistent SNP
probe correlation (either between twins or between longitudinal samples from the
same person). After solving a swap between two methylation samples identiﬁed by
MixupMapper (and conﬁrmed by the other checks) by re-swapping methylation
data IDs (leaving 128 samples with issues), 67 samples were excluded based on the
following grounds: only sex mismatch (22 samples), only genotype mismatch
(10 samples), only DNA contamination (27 samples), genotype þ sex mismatch
(6 samples), DNA contamination þ sex mismatch (2 samples). After removal
of these samples, there were still 38 samples with an inconsistent SNP probe
correlation (that is a zygosity mismatch or mismatch between longitudinal
samples), which were all excluded, giving a total of 105 samples (3.3%) excluded
based on failed identity or contamination, on top of the 70 samples excluded based
on bad quality of the methylation data.
Finally, for 22 persons with Illumina 450k methylation data available from
blood and buccal samples, the 65 SNP probes conﬁrmed that blood and buccal
samples indeed belonged to the same individual.
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Exploration of technical and biological confounding. To get an impression of the
impact of technical and biological effects on overall variation in methylation,
principle component analysis (PCA) was performed on the raw genome-wide
methylation data (Supplementary Table 4; Supplementary Fig. 26), and the cor-
relation between PC scores and several known technical batches and biological
outcomes were computed. PC1 related to sex (r¼ 0.92), PC2 was strongly corre-
lated with position on the array (in particular, array row, r¼ 0.50), PC3 with
several white blood cell counts (for example, lymphocytes: r¼ 0.45), and PC4 with
age (r¼  0.59). Other batch variables (for example, 96-well plate, array, and
scanner) correlated to a smaller degree with multiple components.
Methylation data normalization and covariates correction. To reduce technical
variability between samples while retaining as much biological variation in DNA
methylation as possible, the data were normalized with Functional Normalization,
a between-sample normalization method that normalizes the data using PCs
(the number of which is user speciﬁed) estimated from control probes that are
speciﬁcally designed not to measure biological variation in samples66. There are
several strategies to determine the number relevant PCs in a dataset, including
inspection of the Eigen values or scree plot, and mathematical algorithms that
estimate the number of signiﬁcant PCs. We chose to perform Functional
Normalization with the ﬁrst 4 PCs, because PCA based on the data from control
probes showed that in our data, the ﬁrst 4 PCs correlated with technical variables
(Supplementary Fig. 27), including array row (PC1, r¼  0.71), scanner (PC2,
r¼  0.46), time (days) between blood sampling and hybridization (PC3,
r¼  0.39), and Illumina 450k array barcode (PC4, r¼ 0.18), because the ﬁrst four
PCs had an eigen value 41 (Supplementary Table 5; Supplementary Fig. 28), and
because they explained a large proportion of the variance in control probes (89%),
whereas each of the further PCs only explained a very small proportion of variance
(Supplementary Table 5). We also applied the function EstDimRMT( )
implemented in the R-package isva, which uses Random Matrix Theory (RMT) to
estimate the number of signiﬁcant PCs67, to the control probe data. In convergence
with the criteria outlined above, the RMT method retrieved four signiﬁcant PCs.
Normalized intensity values were converted into beta-values (b) and M
values11; b-values were used for descriptive purposes only because of their
biological interpretability, while M values were used as input for all analyses.
The b-value, which represents the methylation level at a CpG for an individual and
ranges from 0 to 1, is calculated as:
b ¼ M= MþU þ að Þ
where M¼Methylated signal, U¼Unmethylated signal and a represents a
correction term (100 by default) to control the b-value of probes with very low
overall signal intensity (that is, probes for which MþUB0 after normalization).
The M value is equivalent to a log2 logistic transformation of b:
M value ¼ log2 Mþ a=U þ að Þ ¼ log2 b=1bð Þ:
Genomic annotations. CpGs were mapped to ﬁve gene-centric regions: intergenic
region (410 kb from the nearest transcription start site (TSS)), distal promoter
(minus( )10 kb to 1.5 kb from the nearest TSS), proximal promoter ( 1.5 kb
to plus(þ )500 bp from the nearest TSS), gene body (þ 500 bp to 30 end of the
gene) and downstream region (30 end to þ 5 kb from 30 end), and to CGIs (CG
content450%, length4200 bp and observed/expected ratio of CpGs40.6), CGI
shore (2-kb region ﬂanking CGI), CGI shelf (2-kb region ﬂanking CGI shore) and
non-CGI regions, as described by Slieker et al41. Tests for enrichment among
gene-centric and CGI-centric genomic categories were performed with chi-squared
tests in R with the function chisq.test() and Bonferroni correction for the total
number of performed w2-tests (N tests¼ 117) was applied to determine statistical
signiﬁcance (a¼ 0.05/117¼ 4.27 10 4). The eFORGE analysis tool (http://
eforge.cs.ucl.ac.uk/) was used to test for enrichment among DHSs mapped by the
Epigenomics Roadmap Consortium (http://www.ncbi.nlm.nih.gov/epigenomics,68),
selecting the top 1,000 probes for analyses with 41,000 signiﬁcant sites.
We also annotated previously published CpGs that predict ‘DNA methylation
age’18, CpGs associated with smoking status8, BMI3, lipid levels6 and metabolite
levels42.
Heritable and environmental inﬂuences on DNA methylation. To facilitate
computations, missing methylation data (0.04–2.14% of genome-wide probes
per individual, mean¼ 0.1%) were imputed with the R-package impute. Before
analysis, the normalized methylation M values were corrected for sex, age, array
row, 96-well plate (dummy coded), white blood cell percentages (neutrophils,
monocytes and eosinophils; assessed at sample collection), and the ﬁrst ten PCs
derived from the genotype data, with the lm function in R. All analyses that
included genome-wide SNP data were performed on the residuals derived after
correcting for these covariates. All other analyses (that is, twin correlations and
twin models, longitudinal analyses and blood–buccal comparison) were performed
on the residuals derived after correcting for the afore mentioned covariates minus
the genotype PCs.
The impact of heritable and environmental inﬂuences on the methylome was
assessed with the classical twin design and with a SNP-based method. Based on the
data from twins, a ﬁrst impression of the classical twin heritability (h2twins) at each
methylation site (CpGi) was obtained as follows:
h2twins CpGið Þ ¼ 2 rMZ rDZð Þ;
where rMZ and rDZ are the correlations of DNA methylation level at one CpG site
between the MZ, and between the DZ twins, respectively.
Next, genetic models that decomposed variation into additive genetic (A),
non-additive genetic (D), common environmental (C) and unique environmental
(E) components were ﬁtted to the methylation data of the twins (classical twin
method69) using maximum likelihood estimation in custom software. The
statistical signiﬁcance of the variance components was evaluated by means
of likelihood ratio tests. These models allow estimation of the proportion of
variance in DNA methylation attributable to total additive genetic effects
(a2, which represents the same variance component as h2twins), non-additive
genetic effects (d2), common environment (c2) and unique environment (e2).
The variables a2, h2, c2, d2 and e2 represent variance components expressed as a
proportion of total variance.
Having established that additive genetic (A) and unique environmental effects
(E) are the main sources of variation in the methylome, we proceeded to estimate
the proportion of variance attributable to the additive effects of all measured SNPs
(h2SNPs), and to test for interactions of total additive genetic effects and
environmental effects with age and sex. In these analyses, linear mixed models were
ﬁtted in which the covariance of DNA methylation between all individuals
(including non-twin family members) was modelled as a function of measured
genetic relationships based on SNP data. The approach outlined by Zaitlen et al.38
was applied, which makes use of two GRMs: a GRM describing the relationships
between all individuals (GRMIBSnn) and a second GRM in which all
genetic relationships o0.05 IBS (distant genetic relationships) are set to zero
(GRMIBS40:05nn ), making the estimates of genetic relatedness equivalent to the
proportion in the genome shared identity-by-descent (IBD). In essence the
covariance between individuals for DNA methylation level at CpGi is modelled as a
function of the (very small) genetic covariance between individuals in the
population and the (larger) genetic covariance between relatives. Genome-wide
SNPs from the Affymetrix6 array (MAF40.01) were used to construct a GRM with
the software programme genome-wide complex trait analysis (GCTA)59. For each
CpG, we modelled the expected covariance as a function of the GRMs, the additive
genetic variance (s2IBD), and the variance explained by genome-wide SNPs (s
2
SNPs)
as follows:
cov CpGið Þnn¼ GRMIBSnn  s2SNPs þGRMIBS40:05nn  ðs2IBD s2SNPsÞþ Inn  s2e ;
where cov(CpGi)n*n is the expected covariance of DNA methylation at CpGi
between individuals, adjusted for covariates, s2SNPs is the variance explained by all
SNPs, the term ðs2IBD  s2SNPsÞ denotes the difference between the total genetic
variance and the variance explained by SNPs, and s2e reﬂects the variance
attributable to residual effects (‘unique environment’, which may include
environmental inﬂuences unique to each individual, stochastic inﬂuences
and measurement error). The total heritability (h2IBD) was calculated as:
h2IBD¼ s2IBD/ðs2IBD þ s2e ). The proportion of variance explained by genome-wide
SNPs was calculated as: h2SNPs¼ s2SNPs/ðs2IBD þs2e ) and the proportion of the
heritability explained by SNPs was calculated as: h2SNPs/h2IBD.
Genome by sex interaction effects on DNA methylation were investigated with
the following model, with sex coded 0/1:
cov CpGið Þnn¼ diag sIBD þbIBD SexSex1nð ÞGRMIBS40:05nn
diagðsIBD þbIBD SexSex1nÞþ diag se þbIBD SexSex1nð Þ
Inndiag se þbe SexSex1nð Þ;
where bIBD-sex is the regression coefﬁcient for the interaction of genetic effects
with sex, and be-sex is the regression coefﬁcient for the interaction of residual effects
with sex. These methods are described in detail by Nivard et al.70 (MGN.,
Middeldorp C.M., Lubke G., JJH, Abdellaoui A., DIB., CVD. Detection
of gene–environment interaction in pedigree data using genome-wide genotypes,
under review). This parameterization of the interaction effect is equivalent the
method proposed by Purcell71.
Genome by age interaction effects on DNA methylation were investigated with
the following model, with age z-transformed:
covðCpGiÞnn ¼ diag sIBDþ bIBDAgeAge1n
 
GRMIBS40:05nn
diagðsIBD þ bIBDAgeAge1nÞþ diag se þbIBDAgeAge1n
 
 Inndiag se þ beAgeAge1n
 
;
where bIBD-Age is the regression coefﬁcient for the interaction of genetic effects with
age, and be-Age is the regression coefﬁcient for the interaction of residual effects
with age.
Before the analyses based on genome-wide SNP data, methylation levels were
standardized (z-transformation) to facilitate computations. A small proportion of
CpGs for which a model could not be ﬁtted successfully was discarded (see results).
The P values of each of the four interaction effects (genetic and environmental
variance by age and sex) were derived with a w2-test (1 degree of freedom), where
w2¼ (b/s.e.)2. Statistical signiﬁcance of interaction P values was assessed after
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Bonferroni correction for the number of CpGs for which estimates were
successfully obtained (a¼ 0.05/NCpGs; alpha ACE twin modelling¼ 1.2 10 7,
alpha interaction analyses¼ 1.3 10 7). The correspondence between the
classical twin model-based heritability (a2) and heritability estimated with the
GRM approach (h2) was evaluated by computing the correlation between the value
of a2 and the corresponding value of h2. Computer code is available upon request
from the authors.
Longitudinal correlation and blood–buccal correlation. Data from individuals
with blood samples obtained at two repeated measures were analysed to calculate
the correlation between DNA methylation level at time point 1 and DNA
methylation level at time point 2 for each CpG site (mean interval¼ 5 years). After
obtaining an estimate of heritability and a longitudinal correlation for each CpG,
the correlation between genome-wide estimates of (twin-based) heritability and
genome-wide estimates of the longitudinal correlation was estimated to examine
the relationship between longitudinal stability and the heritability of DNA
methylation level. Data from individuals with Illumina 450k methylation data from
blood samples and buccal samples were analysed to calculate the correlation
between DNA methylation level in blood and buccal for each CpG. Before this
analysis, the buccal methylation data (M values) were corrected for sex, array row
and assessment batch (two levels). Blood–buccal correlations for all CpGs were
correlated with h2twins to examine the relationship between the heritability in blood
and the extent to which between-individual variation in DNA methylation level is
shared across tissues.
References
1. Meissner, A. et al. Genome-scale DNA methylation maps of pluripotent and
differentiated cells. Nature 454, 766–770 (2008).
2. Mill, J. & Heijmans, B. T. From promises to practical strategies in epigenetic
epidemiology. Nat. Rev. Genet. 14, 585–594 (2013).
3. Dick, K. J. et al. DNA methylation and body-mass index: a genome-wide
analysis. Lancet 383, 1990–1998 (2014).
4. Hidalgo, B. et al. Epigenome-wide association study of fasting measures of
glucose, insulin, and HOMA-IR in the Genetics of Lipid Lowering Drugs and
Diet Network study. Diabetes 63, 801–807 (2014).
5. Liu, Y. et al. Epigenome-wide association data implicate DNA methylation as
an intermediary of genetic risk in rheumatoid arthritis. Nat. Biotechnol. 31,
142–147 (2013).
6. Pfeifferm, L. et al. DNA methylation of lipid-related genes affects blood lipid
levels. Circ. Cardiovasc. Genet. 8, 334–342 (2015).
7. van Mil, N. H. et al. DNA methylation proﬁles at birth and child ADHD
symptoms. J. Psychiatr. Res. 49, 51–59 (2014).
8. Guida, F. et al. Dynamics of smoking-induced genome-wide methylation changes
with time since smoking cessation. Hum. Mol. Genet. 24, 2349–2359 (2015).
9. Grundberg, E. et al. Global analysis of DNA methylation variation in adipose
tissue from twins reveals links to disease-associated variants in distal regulatory
elements. Am. J. Hum. Genet. 93, 876–890 (2013).
10. Gamazon, E. R. et al. Enrichment of cis-regulatory gene expression SNPs and
methylation quantitative trait loci among bipolar disorder susceptibility
variants. Mol. Psychiatry 18, 340–346 (2013).
11. Zhang, X. et al. Linking the genetic architecture of cytosine modiﬁcations with
human complex traits. Hum. Mol. Genet. 23, 5893–5905 (2014).
12. Shi, J. et al. Characterizing the genetic basis of methylome diversity in
histologically normal human lung tissue. Nat. Commun. 5, 3365 (2014).
13. Boks, M. P. et al. The relationship of DNA methylation with age, gender and
genotype in twins and healthy controls. PLoS ONE 4, e6767 (2009).
14. Tapp, H. S. et al. Nutritional factors and gender inﬂuence age-related DNA
methylation in the human rectal mucosa. Aging Cell 12, 148–155 (2013).
15. Liu, J., Morgan, M., Hutchison, K. & Calhoun, V. D. A study of the inﬂuence of
sex on genome wide methylation. PLoS ONE 5, e10028 (2010).
16. Bell, J. T. et al. Epigenome-wide scans identify differentially methylated regions
for age and age-related phenotypes in a healthy ageing population. PLoS. Genet.
8, e1002629 (2012).
17. Horvath, S. et al. Aging effects on DNA methylation modules in human brain
and blood tissue. Genome Biol. 13, R97 (2012).
18. Horvath, S. DNA methylation age of human tissues and cell types. Genome
Biol. 14, R115 (2013).
19. Teschendorff, A. E. et al. Age-dependent DNA methylation of genes that are
suppressed in stem cells is a hallmark of cancer. Genome Res. 20, 440–446
(2010).
20. Kaminsky, Z., Wang, S. C. & Petronis, A. Complex disease, gender and
epigenetics. Ann. Med. 38, 530–544 (2006).
21. Bjornsson, H. T., Fallin, M. D. & Feinberg, A. P. An integrated epigenetic and
genetic approach to common human disease. Trends Genet. 20, 350–358 (2004).
22. Rideout, III W. M., Eggan, K. & Jaenisch, R. Nuclear cloning and epigenetic
reprogramming of the genome. Science 293, 1093–1098 (2001).
23. Cortijo, S. et al. Mapping the epigenetic basis of complex traits. Science 343,
1145–1148 (2014).
24. Morgan, H. D., Sutherland, H. G., Martin, D. I. & Whitelaw, E. Epigenetic
inheritance at the agouti locus in the mouse. Nat. Genet. 23, 314–318 (1999).
25. McRae, A. F. et al. Contribution of genetic variation to transgenerational
inheritance of DNA methylation. Genome Biol. 15, R73 (2014).
26. Gordon, L. et al. Neonatal DNA methylation proﬁle in human twins is speciﬁed
by a complex interplay between intrauterine environmental and genetic factors,
subject to tissue-speciﬁc inﬂuence. Genome Res. 22, 1395–1406 (2012).
27. Lillycrop, K. A., Phillips, E. S., Jackson, A. A., Hanson, M. A. & Burdge, G. C.
Dietary protein restriction of pregnant rats induces and folic acid
supplementation prevents epigenetic modiﬁcation of hepatic gene expression in
the offspring. J. Nutr. 135, 1382–1386 (2005).
28. Tobi, E. W. et al. DNA methylation differences after exposure to prenatal
famine are common and timing- and sex-speciﬁc. Hum. Mol. Genet. 18,
4046–4053 (2009).
29. Kundakovic, M. et al. Sex-speciﬁc epigenetic disruption and behavioral changes
following low-dose in utero bisphenol A exposure. Proc. Natl Acad. Sci. USA
110, 9956–9961 (2013).
30. Fraga, M. F. et al. Epigenetic differences arise during the lifetime of
monozygotic twins. Proc. Natl Acad. Sci. USA 102, 10604–10609 (2005).
31. Talens, R. P. et al. Epigenetic variation during the adult lifespan: cross-sectional
and longitudinal data on monozygotic twin pairs. Aging Cell 11, 694–703
(2012).
32. Bocklandt, S. et al. Epigenetic predictor of age. PLoS ONE 6, e14821 (2011).
33. Martino, D. et al. Longitudinal, genome-scale analysis of DNA methylation in
twins from birth to 18 months of age reveals rapid epigenetic change in early
life and pair-speciﬁc effects of discordance. Genome Biol. 14, R42 (2013).
34. Ma, Y. et al. Genetic variants modify the effect of age on APOE methylation in
the Genetics of Lipid Lowering Drugs and Diet Network study. Aging Cell 14,
49–59 (2015).
35. Flores, K. G. et al. Sex-speciﬁc association of sequence variants in CBS and
MTRR with risk for promoter hypermethylation in the lung epithelium of
smokers. Carcinogenesis 33, 1542–1547 (2012).
36. Teschendorff, A. E., West, J. & Beck, S. Age-associated epigenetic drift:
implications, and a case of epigenetic thrift? Hum. Mol. Genet. 22, R7–R15
(2013).
37. Yang, J. et al. Genome partitioning of genetic variation for complex traits using
common SNPs. Nat. Genet. 43, 519–525 (2011).
38. Zaitlen, N. et al. Using extended genealogy to estimate components of
heritability for 23 quantitative and dichotomous traits. PLoS Genet. 9, e1003520
(2013).
39. Bernstein, B. E. et al. The NIH roadmap epigenomics mapping consortium.
Nat. Biotechnol. 28, 1045–1048 (2010).
40. Shah, S. et al. Genetic and environmental exposures constrain epigenetic drift
over the human life course. Genome Res. 24, 1725–1733 (2014).
41. Slieker, R. C. et al. Identiﬁcation and systematic annotation of tissue-speciﬁc
differentially methylated regions using the Illumina 450k array. Epigenetics
Chromatin 6, 26 (2013).
42. Petersen, A. K. et al. Epigenetics meets metabolomics: an epigenome-wide
association study with blood serum metabolic traits. Hum. Mol. Genet. 23,
534–545 (2014).
43. Marioni, R. E. et al. DNA methylation age of blood predicts all-cause mortality
in later life. Genome Biol. 16, 25 (2015).
44. Marioni, R. E. et al. The epigenetic clock is correlated with physical and
cognitive ﬁtness in the Lothian Birth Cohort 1936. Int. J. Epidemiol. 44,
1388–1396 (2015).
45. Choufani, S. et al. A novel approach identiﬁes new differentially methylated
regions (DMRs) associated with imprinted genes. Genome Res. 21, 465–476
(2011).
46. Illingworth, R. et al. A novel CpG island set identiﬁes tissue-speciﬁc
methylation at developmental gene loci. PLoS Biol. 6, e22 (2008).
47. Doi, A. et al. Differential methylation of tissue- and cancer-speciﬁc CpG island
shores distinguishes human induced pluripotent stem cells, embryonic stem
cells and ﬁbroblasts. Nat. Genet. 41, 1350–1353 (2009).
48. Irizarry, R. A. et al. The human colon cancer methylome shows similar
hypo- and hypermethylation at conserved tissue-speciﬁc CpG island shores.
Nat. Genet. 41, 178–186 (2009).
49. Ziller, M. J. et al. Charting a dynamic DNA methylation landscape of the
human genome. Nature 500, 477–481 (2013).
50. Teh, A. L. et al. The effect of genotype and in utero environment on
interindividual variation in neonate DNA methylomes. Genome Res. 24,
1064–1074 (2014).
51. van der Sluis, S., Willemsen, G., de Geus, E. J., Boomsma, D. I. & Posthuma, D.
Gene-environment interaction in adults’ IQ scores: measures of past and
present environment. Behav. Genet. 38, 348–360 (2008).
52. Tobi, E. W. et al. DNA methylation signatures link prenatal famine exposure to
growth and metabolism. Nat. Commun. 5, 5592 (2014).
53. Hanna, C. W. et al. DNA methylation changes in whole blood is associated with
exposure to the environmental contaminants, mercury, lead, cadmium and
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11115
12 NATURE COMMUNICATIONS | 7:11115 | DOI: 10.1038/ncomms11115 | www.nature.com/naturecommunications
bisphenol A, in women undergoing ovarian stimulation for IVF. Hum. Reprod.
27, 1401–1410 (2012).
54. Essex, M. J. et al. Epigenetic vestiges of early developmental adversity:
childhood stress exposure and DNA methylation in adolescence. Child Dev. 84,
58–75 (2013).
55. Vandiver, A. R. et al. Age and sun exposure-related widespread genomic blocks
of hypomethylation in nonmalignant skin. Genome Biol. 16, 80 (2015).
56. Willemsen, G. et al. The Netherlands Twin Register biobank: a resource for
genetic epidemiological studies. Twin Res. Hum. Genet. 13, 231–245 (2010).
57. van Dongen, J. et al. Epigenetic variation in monozygotic twins: a genome-wide
analysis of DNA methylation in buccal cells. Genes (Basel) 5, 347–365 (2014).
58. Genome of the Netherlands Consortium. Whole-genome sequence variation,
population structure and demographic history of the Dutch population. Nat.
Genet. 46, 818–825 (2014).
59. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-
wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).
60. Bibikova, M. et al. High density DNA methylation array with single CpG site
resolution. Genomics 98, 288–295 (2011).
61. R Core Team.. R: A Language and Environment for Statistical Computing
(R Foundation for Statistical Computing, Vienna, Austria. URL http://www.
R-project.org/, 2013).
62. van Iterson, M. et al. MethylAid: visual and interactive quality control of large
Illumina 450k datasets. Bioinformatics 30, 3435–3437 (2014).
63. Chen, Y. A. et al. Discovery of cross-reactive probes and polymorphic CpGs
in the Illumina Inﬁnium HumanMethylation450 microarray. Epigenetics 8,
203–209 (2013).
64. Aryee, M. J. et al. Minﬁ: a ﬂexible and comprehensive bioconductor package for
the analysis of Inﬁnium DNA methylation microarrays. Bioinformatics 30,
1363–1369 (2014).
65. Westra, H. J. et al. MixupMapper: correcting sample mix-ups in genome-wide
datasets increases power to detect small genetic effects. Bioinformatics 27,
2104–2111 (2011).
66. Fortin, J. P. et al. Functional normalization of 450k methylation array data
improves replication in large cancer studies. Genome Biol. 15, 503 (2014).
67. Teschendorff, A. E., Zhuang, J. & Widschwendter, M. Independent surrogate
variable analysis to deconvolve confounding factors in large-scale microarray
proﬁling studies. Bioinformatics 27, 1496–1505 (2011).
68. Stergachis, A. B. et al. Developmental fate and cellular maturity encoded in
human regulatory DNA landscapes. Cell 154, 888–903 (2013).
69. van Dongen, J., Slagboom, P. E., Draisma, H. H., Martin, N. G. &
Boomsma, D. I. The continuing value of twin studies in the omics era. Nat. Rev.
Genet. 13, 640–653 (2012).
70. Michel, G. N. et al. Detection of gene -environment interaction in pedigree data
using genome-wide genotypes, under review.
71. Purcell, S. Variance components models for gene-environment interaction in
twin analysis. Twin. Res. 5, 554–571 (2002).
Acknowledgements
We thank the twins and their family members who participate in the studies of the
Netherlands Twin Register. This study was funded by: BBRMI-NL-ﬁnanced BIOS
Consortium (NWO 184.021.007), and Genetics of Mental Illness, a lifespan approach to
the genetics of childhood and adult neuropsychiatric disorders and comorbid conditions
(ERC-230374). JvD is supported by ACTION. ACTION receives funding from the
European Union Seventh Framework Program (FP7/2007-2013) under grant agreement
no 602768. MV is supported by Royal Netherlands Academy of Science Professor Award
(PAH/6635) to DIB. CB was supported by EpiTrain (EU-FP7 316758).
Author contributions
J.v.D. and M.G.N. contributed equally. B.T.H., G.W., P.E.S. and D.I.B. jointly supervised
research. J.v.D., B.T.H., M.G.N., G.W., P.E.S. and D.I.B. conceived and designed the
experiments. E.A.E., G.E.D., the BIOS Consortium, H.E.S., and J.B.v.M. performed the
experiments. J.v.D., M.G.N. and C.B. performed statistical analysis. J.v.D., B.T.H.,
M.G.N., J.J.H., Q.H., C.V.D., E.A.E., M.V.I. and the BIOS consortium analysed the
data. M.G.N., C.V.D., M.v.I., C.B., S.B. and the BIOS consortium contributed
reagents/materials/analysis tools. J.v.D., B.T.H., M.G.N., G.W., E.A.E., G.E.D., R.J.,
J.B.v.M., P.E.S. and D.I.B. wrote the paper. B.T.H., P.E.S. and D.I.B. contributed
equally.
Additional information
Accession codes: The HumanMethylation450 BeadChip data described in this paper are
available in the European Genome-phenome Archive (EGA), under the accession code
EGAD00010000887.
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing ﬁnancial interests: The authors declare no competing ﬁnancial
interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: van Dongen, J. et al. Genetic and environmental inﬂuences
interact with age and sex in shaping the human methylome. Nat. Commun. 7:11115
doi: 10.1038/ncomms11115 (2016).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
BIOS Consortium
Peter A.C.’t Hoen7, Rene´ Pool1, Marleen M.J. van Greevenbroek8, Coen D.A. Stehouwer8,
Carla J.H. van der Kallen8, Casper G. Schalkwijk8, Cisca Wijmenga9, Sasha Zhernakova9, Ettje F. Tigchelaar9,
Marian Beekman3, Joris Deelen3, Diana van Heemst10, Jan H. Veldink11, Leonard H. van den Berg11,
Cornelia M. van Duijn12, Bert A. Hofman13, Andre´ G. Uitterlinden6, P. Mila Jhamai6, Michael Verbiest6,
Marijn Verkerk6, Ruud van der Breggen3, Jeroen van Rooij6, Nico Lakenberg3, Hailiang Mei14, Jan Bot15,
Dasha V. Zhernakova9, Peter van’t Hof14, Patrick Deelen9, Irene Nooren15, Matthijs Moed3, Martijn Vermaat7,
Rene´ Luijk3, Marc Jan Bonder9, Freerk van Dijk16, Michiel van Galen7, Wibowo Arindrarto14,
Szymon M. Kielbasa17, Morris A. Swertz16, Erik W. van Zwet17, Aaron Isaacs12, Lude Franke9.
7Department of Human Genetics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands. 8Department of Internal Medicine and School for
Cardiovascular Diseases (CARIM), Maastricht University Medical Center, 6200 MD Maastricht, The Netherlands. 9Department of Genetics, University of
Groningen, University Medical Centre Groningen, 9700 RB Groningen, The Netherlands.10Department of Gerontology and Geriatrics, Leiden University
Medical Center, 2300 RC Leiden, The Netherlands. 11Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, 3508 GA
Utrecht, The Netherlands. 12Department of Genetic Epidemiology, ErasmusMC, 3000 CA Rotterdam, The Netherlands. 13Department of Epidemiology,
ErasmusMC, 3000 CA Rotterdam, The Netherlands. 14Sequence Analysis Support Core, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
15SURFsara, 1090 GP Amsterdam, The Netherlands. 16Genomics Coordination Center, University Medical Center Groningen, University of Groningen, 9700
RB Groningen, The Netherlands. 17Medical Statistics Section, Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, 2300
RC Leiden, The Netherlands.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11115 ARTICLE
NATURE COMMUNICATIONS | 7:11115 | DOI: 10.1038/ncomms11115 | www.nature.com/naturecommunications 13
